Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Carcinoma × TVB-2640 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms, Castration-Resistant 1 Neoplasms 1 Glioblastoma 1 Colonic Neoplasms 1 Astrocytoma 1 Advanced Breast Carcinoma 1

Interventions

trastuzumab biosimilar HLX02 1 exemestane 1 X-Rays 1 Trastuzumab 1 Taxes 1 TVB-2640 1 Specimen Handling 1 Paclitaxel 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Fulvestrant 1 Disulfides 1 CT-P6 1 Biopsy 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03179904 2026-02-24

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Mayo Clinic

Phase 2 Active not recruiting

17 enrolled 10 charts

Advanced Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡